Tellgen Corporation (300642.SZ)

14.05 +0.07 (+0.50%) At close: 03:04PM CST

Tellgen Corporation

Building 1
Lane 572 No. 115, Bibo Road Free Trade Zone, Pudong District
Shanghai 201203
China
86 21 5027 3499
https://www.tellgen.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 574

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Jian Er Yao	Non-Independent Chairman of Board & GM	N/A	N/A	1970
Ms. Jiajin Zhang	Financial Manager & Accounting Supervisor	N/A	N/A	1980
Mr. En Huan Yang	Deputy GM & Non-Independent Director	N/A	N/A	1982
Mr. Xiaoqing Wang	Deputy GM, Secretary of Board of Directors, Director of GM's Office & Non-Independent Director	N/A	N/A	1979
Mr. Ye Sheng	Director of R&D and Deputy GM	N/A	N/A	1981

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. The company offers tumor markers; cervical cancer and HPV testing kits; Y chromosome microdeletions test kits; autoimmune; cardiovascular and inflammation; biochemistry kits; DNA methylation testing kits; and molecular detection of COVID-19 and others. It also provides diagnostic reagents/testing instruments and assembly lines. The company was founded in 2003 and is based in Shanghai, China.

Corporate governance

Tellgen Corporation’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.